Charles Silberstein
2021
In 2021, Charles Silberstein earned a total compensation of $1.3M as Chief Financial Officer at Applied Therapeutics, a 86% decrease compared to previous year.
Compensation breakdown
| Bonus | $183,440 |
|---|---|
| Option Awards | $195,840 |
| Salary | $458,550 |
| Stock Awards | $452,176 |
| Other | $1,529 |
| Total | $1,291,535 |
Silberstein received $458.6K in salary, accounting for 36% of the total pay in 2021.
Silberstein also received $183.4K in bonus, $195.8K in option awards, $452.2K in stock awards and $1.5K in other compensation.
Rankings
In 2021, Charles Silberstein's compensation ranked 7,846th out of 12,415 executives tracked by ExecPay. In other words, Silberstein earned more than 36.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,846 out of 12,415 | 37th |
Division Manufacturing | 3,466 out of 5,508 | 37th |
Major group Chemicals And Allied Products | 1,540 out of 2,378 | 35th |
Industry group Drugs | 1,369 out of 2,099 | 35th |
Industry Pharmaceutical Preparations | 1,013 out of 1,549 | 35th |
Source: SEC filing on April 15, 2022.
Silberstein's colleagues
We found two more compensation records of executives who worked with Charles Silberstein at Applied Therapeutics in 2021.